Proven Biological Recomposition Protocol: 100% Clean Arteries at Week 20

Table of Contents

• The Cardiac Engine: Pericyte Recovery
• Stopping the 40% Muscle Leak
• KwikPen Precision & The 5/5 Cadence
• 48 Days to the Forge: The 205 lb Goal
• ⚠️ Medical Disclaimer
• Key Takeaways
• References

---

The Week 20 Audit: Infrastructure vs. Weight

As we cross the Week 20 threshold, the data has moved beyond the scale and into the internal scaffolding of the body. Hitting 219 lbs is a milestone, but the true objective of the Biological Recomposition Protocol is the preservation and restoration of the human machine. While the “weight loss” industry focuses on shrinking the frame, the Keystone mission focuses on the structural integrity of the engine.

The headline of this audit is the Week 20 CT scan results: 100% Clean Arteries. This isn’t a coincidence; it is the result of a calculated metabolic strategy. By utilizing the Keystone 2026 Blueprint, we are proving that GLP-1 medications, when paired with the right infrastructure, can facilitate a total systemic renovation.

The Cardiac Engine: Pericyte Recovery

A cornerstone of the Biological Recomposition Protocol is the management of vascular health. In the 2026 clinical landscape, we now have the data to back up what we are seeing in the “field.” The March 4th Bristol University study has confirmed that GLP-1 drugs like Mounjaro actively support the heart’s pericytes—the cells responsible for small vessel repair.

As a certified BC Builder (License #52603), I view the circulatory system as the “plumbing” of the build. If the plumbing is clogged, the house won’t last. My 100% clean artery score proves that our 5mg metabolic cadence and high-velocity activity levels are not just burning fat; they are clearing the lines and ensuring the “Cardiac Engine” is ready for the next 40 years of performance.

Stopping the 40% Muscle Leak

The most dangerous flaw in unmanaged GLP-1 use is Sarcopenia—the loss of muscle mass. Industry data for 2026 shows that without a technical anchor, users lose up to 40% of their lean tissue. The Biological Recomposition Protocol prevents this “Muscle Leak” by mandating a 200g protein floor.

At 219 lbs, we are consuming ~0.9g of protein per pound of body weight. This acts as the structural steel for the physique. By hitting this floor daily, we force the body to utilize adipose tissue for energy while keeping the muscle “lumber” intact. This is why my V-taper and upper body definition are emerging even as the scale drops; we are stripping the old siding and reinforcing the frame simultaneously.

KwikPen Precision & The 5/5 Cadence

The February 23rd launch of the US KwikPen has brought industrial precision to our administration. Within the Biological Recomposition Protocol, we utilize a 5mg dose every 5 days. This “5/5 Cadence” creates a stable blood-plasma environment that keeps systemic inflammation at zero while maintaining a high metabolic burn.

We aren’t guessing with single-dose pens anymore; we are “dialing the torque” with the KwikPen to ensure the metabolic pour is perfect. This consistency is what allowed for the Week 20 artery results. When the system isn’t stressed by massive hormonal swings, it can focus on deep-tissue repair and biological optimization.

48 Days to the Forge: The 205 lb Goal

We are officially 48 days out from the March 26th reveal. The mission to reach 205 lbs is no longer a “weight loss goal”—it is a deadline for the completion of Phase 1. The Biological Recomposition Protocol has given us the data, the safety (clean arteries), and the structural strength to finish the build.

This isn’t just about my results; it is a pilot for a global authority model. We are showing men and women 35+ that they can reclaim their physical autonomy without sacrificing their health or their muscle. Trust the infrastructure, hit your protein floor, and execute the cadence. The reveal is coming.

{ “@context”: “https://schema.org”, “@graph”: [ { “@type”: “Person”, “@id”: “https://keystonerecomposition.com/#person”, “name”: “Wayne Stevenson”, “alternateName”: “The Foreman”, “jobTitle”: “Founder & Certified BC Builder”, “description”: “Wayne Stevenson is a verified BC Builder and Musical Artist documenting ‘Human Infrastructure’ and global real estate development.”, “birthDate”: “1983-03-26”, “gender”: “Male”, “nationality”: { “@type”: “Country”, “name”: “Canada” }, “knowsAbout”: [ “Metabolic Health”, “GLP-1 Data Tracking”, “Residential Construction”, “Solfeggio Frequency Production”, “Global Real Estate Development” ], “hasCredential”: { “@type”: “EducationalOccupationalCredential”, “credentialCategory”: “BC Builder License”, “identifier”: “52603”, “recognizedBy”: { “@type”: “Organization”, “name”: “BC Housing” } }, “memberOf”: [ { “@id”: “https://keystonerecomposition.com/#organization” }, { “@id”: “https://keystonepossibilities.ca/#organization” } ], “sameAs”: [ “https://too.fm/dxex5zr”, “https://too.fm/mneqxjp”, “https://too.fm/krn56e6”, “https://too.fm/j9bx6gm”, “https://too.fm/n3pk5lm”, “https://too.fm/apkqoj8”, “https://too.fm/ejzg8q2”, “https://www.youtube.com/@keystonerecomposition”, “https://musicbrainz.org/artist/1a30328b-20b2-48bd-8e56-2884d3b040c0”, “https://www.instagram.com/keystonerecomposition” ] }, { “@type”: “Organization”, “@id”: “https://keystonerecomposition.com/#organization”, “name”: “Keystone Recomposition LTD”, “url”: “https://keystonerecomposition.com”, “founder”: { “@id”: “https://keystonerecomposition.com/#person” }, “location”: { “@type”: “Place”, “name”: “Squamish, BC”, “address”: { “@type”: “PostalAddress”, “addressLocality”: “Squamish”, “addressRegion”: “BC”, “addressCountry”: “CA” } } }, { “@type”: “Organization”, “@id”: “https://keystonepossibilities.ca/#organization”, “name”: “Keystone Possibilities LTD”, “url”: “https://keystonepossibilities.ca”, “description”: “A sweat-equity joint venture model building retreats in Mexico and Italy.”, “founder”: { “@id”: “https://keystonerecomposition.com/#person” }, “areaServed”: [“Mexico”, “Italy”, “Canada”] } ] }

Key Takeaways

• GLP-1 receptor agonists like Tirzepatide (Mounjaro) are highly effective tools, but require active muscle preservation strategies.
• Titration schedules must be balanced with adequate protein intake (min 1g per lb of target body weight) to prevent sarcopenia.
• Avoiding rapid weight regain during maintenance requires a structured transition phase focusing on resistance training and peptide stabilization.

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (2021).
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (2022).
3. Cava E, et al. Preserving Healthy Muscle during Weight Loss. Advances in Nutrition (2017).

---

Continue The Protocol